Monoclonal antibodies protected aged, diabetic rhesus macaque monkeys from disease due to SARS-CoV-2 and reduced signs of inflammation, including in cerebrospinal fluid, according to a new study from UC Davis researchers.
Dr. Bart Weimer co-authored an Op-ed for TandFOnline about COVID-19's adaptive evolution during the pandemic and implications of new SARS-CoV-2 variants on public health policies.
A new study led by UC Davis shows how SARS-CoV-2, the virus that causes COVID-19, and SARS-CoV-1, which caused the 2003 SARS outbreak, are related to each other.
In a promising result for the success of vaccines against COVID-19, rhesus macaque monkeys infected with the human coronavirus SARS-CoV-2 developed protective immune responses that might be reproduced with a vaccine. Results suggest lasting immunity after infection.
Last month saw the first shots of COVID-19 vaccines being given to health care workers at UC Davis and elsewhere. What’s in these vaccines? How do they work, how effective are they, and is this really the beginning of the end of the pandemic? Join us this Thursday, Jan 14th, to hear live from two UC Davis experts in vaccines and vaccination.
Max, a 4-year-old male Large Munsterlander, enjoys walks with his owners, Dr. Stevan Cavalier—a retired physician—and his wife Stephany near their home in the Bay Area. While they take precautions for their dogs due to the presence of foxtails in the area, it’s not always a guarantee that the dogs will stay completely away from the dangerous plants. Recently, Max had a decreased appetite, was lethargic, and had a fever and an increased respiratory rate. He was immediately taken to a local veterinary clinic.
Researchers at the University of California, Davis, have developed a new web application that allows users to track COVID-19 cases and testing across the globe.
